The Delhi High Court is set to decide on Monday whether it has the jurisdiction to quash show-cause notices issued by the Maharashtra FDA to celebrity endorsers Shah Rukh Khan, Ajay Devgn, and Tiger Shroff regarding Vimal Elaichi advertisements.

  • Delhi HC will decide on its territorial jurisdiction to hear the PB Agro LLP plea.
  • Maharashtra FDA alleges Vimal Elaichi ads are surrogate promotions for banned Pan Masala.
  • Celebrity endorsers SRK, Ajay Devgn, and Tiger Shroff are at the center of the legal dispute.

New Delhi: A high-stakes legal battle involving Bollywood's biggest superstars—Shah Rukh Khan, Ajay Devgn, and Tiger Shroff—is reaching a critical juncture. The Delhi High Court is scheduled to deliver its order this Monday regarding the jurisdiction to hear a petition filed by PB Agro LLP, the makers of Vimal Elaichi. The company is seeking to quash show-cause notices issued to its brand ambassadors by the Maharashtra Food and Drug Administration (FDA).

The controversy stems from allegations of 'surrogate advertising.' The Maharashtra FDA contends that the advertisements for Vimal Elaichi are strategically designed to promote Vimal Pan Masala, a product that is banned in the state. The regulator has demanded that the actors provide documentation to prove the products are distinct and has directed the withdrawal of promotional material from digital platforms.

Read Also:Two Arrested in Connection with Toronto US Consulate Shooting

Why This Matters

BozokMedia analysis shows that this case is a litmus test for the enforcement of surrogate advertising laws in India. The outcome will not only impact the legal standing of high-profile celebrity endorsements but will also define the territorial boundaries of state regulators versus central judicial oversight in advertising disputes.

Legal experts suggest that the court's decision on jurisdiction will set a massive precedent for how state-level regulatory notices are challenged in higher courts.

In its petition, PB Agro LLP argued that the Maharashtra FDA lacks the authority to halt advertisements and that the notices sent specifically to the actors, rather than the company, aim to cause irreparable reputational harm. The company maintained that Vimal Pan Masala has not been sold in Maharashtra since 2001 and that all current advertising complies with Supreme Court mandates regarding tobacco products.

Historical Background

Surrogate advertising has been a contentious issue in India for decades. As direct advertising for products like alcohol and tobacco became prohibited, brands shifted to using identical brand names for permitted products like soda, music CDs, or cardamom (Elaichi). This practice has led to a continuous tug-of-war between marketing giants and public health regulators.

Did You Know?: The Supreme Court of India has strictly prohibited the advertising of pan masala containing tobacco across the country since 2013.

Frequently Asked Questions

1. What is the core allegation against Vimal Elaichi?
The Maharashtra FDA alleges that the brand uses cardamom (Elaichi) as a cover to promote banned pan masala through surrogate advertising.

2. Why is the case in Delhi High Court?
The petitioner, PB Agro LLP, has approached the Delhi High Court, while the Centre argues the matter should be heard in the Bombay High Court as the notice originated in Maharashtra.